Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Retail health clinics have driven conversation about the convenient and accessible care they could provide since their ...

Q1 2025 Management View CEO David Joyner highlighted a strong start to 2025, reporting adjusted EPS of $2.25 and adjusted ...

CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...

Eli Lilly (NYSE:LLY) shares dropped on Thursday after lowering its full-year outlook amid a decision by CVS Health (NYSE:CVS) ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the Affordable ...

CVS Health Corp.’s Aetna unit will exit the Affordable Care Act insurance market in 2026, the company said after reporting ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

CVS Health reported $1.8 billion in net income for the first quarter, a 58.5% leap, as revenue increased 7% to $94.6 billion.